TrialBMC complementary and alternative medicine2014

Decrease of a specific biomarker of collagen degradation in osteoarthritis, Coll2-1, by treatment with highly bioavailable curcumin during an exploratory clinical trial.

Yves Henrotin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.